Filing Flows › LivaNova (LIVN) › Q3 2025
LivaNova (LIVN) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 5, 2025
LivaNova (LIVN) reported revenue of $358M for the third quarter 2025 (Q3 2025), +12% from a year earlier and +1% from the quarter before. Operating margin was 15.1%, net earnings $26.8M (7.5% of revenue).
LivaNova, Q3 2025: revenue $358M (+12% year over year), operating margin 15.1%, net earnings $26.8M, operating cash flow $85.1M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $358M | +1% | +12% |
| Gross profit | $245M | +2% | +11% |
| Operating profit | $54.0M | -0.3% | +52% |
| Net earnings | $26.8M | -1% | -19% |
| Operating cash flow | $85.1M | +35% | +67% |
| Free cash flow | $62.1M | — | — |
What changed
Revenue was $357.8M in Q3 2025, up 12% year over year and up 1% from the previous quarter.
Gross margin was 68.4%, down 1.0 points from a year earlier. Operating profit was $54.0M, a 15.1% margin (up 3.9 points year over year). Of the extra revenue versus a year earlier, 46% reached operating profit, above the 11% margin then. Operating expenses grew 3% against revenue growth of 12%. Net earnings were $26.8M, down 19% year over year. The effective tax rate was 21.0%.
Operating cash flow was $85.1M (up 67% year over year), 318% of net earnings. Non-cash charges added back $12.2M of depreciation and amortization and $9.9M of share-based compensation. Working capital and other items added $36.1M. After purchases of plant, property, and equipment ($22.9M) and dividends received from investments ($100K), adjusted free cash flow as the company reports it was $62.1M.
Questions
What was LivaNova's revenue in the third quarter 2025?
LivaNova (LIVN) reported revenue of $358M for the third quarter 2025 (Q3 2025), +12% from a year earlier and +1% from the quarter before.
Was LivaNova profitable in the third quarter 2025?
Operating profit was $54.0M (15.1% of revenue) and net earnings $26.8M.
Source: LivaNova 10-Q on SEC EDGAR.